Medical research developments for knee osteoarthritis

Recent medical research has focused on diverse approaches to treating knee osteoarthritis, ranging from biological regeneration to minimally invasive procedures.

Scientists at Stanford Medicine have identified that inhibiting the enzyme 15-PGDH can stimulate cartilage regrowth, a finding that has shown promise in both aging mice and human cartilage samples. Concurrently, Keck Medicine of USC has initiated clinical trials for CX-011, an injection designed to interrupt inflammation-related signaling via the GP130 receptor to prevent cartilage loss.

Other advancements include genicular artery embolization (GAE), a minimally invasive technique that uses microscopic particles to block abnormal blood vessels and reduce inflammation. In a study of 194 patients, roughly 80% reported improvements in pain and mobility. Additionally, engineers at Columbia University are developing the NITRO project, which utilizes 3D-printed living tissue to create biological knee replacements. Early testing indicates these biological joints can withstand forces exceeding 100 kilograms, with potential patient testing projected to begin in approximately 18 months.